ÂÜÀòÂÒÂ×

Guillermo de la Rosa is a scientist at MEDGENOME since April 2022, where leadership is demonstrated in a protein group focused on designing, expressing, and characterizing proteins. Prior experience includes a postdoctoral researcher position at the University of Toronto from March 2019 to April 2022, contributing to the development of scalable synthetic antibodies against snake toxins. Guillermo de la Rosa also earned a PhD at Instituto de Biotecnología UNAM between March 2014 and February 2019, concentrating on the design and expression of animal toxins for universal antivenom development. Educational qualifications encompass a Master's degree in Biochemistry from Universidad Nacional Autónoma de México, a Bachelor's degree from Universidad Autónoma del Estado de Morelos, and a PhD in Biochemistry, Biophysics, and Molecular Biology from Universidad Nacional Autónoma de México.